TCWM
BPMC

Total Clarity Wealth Management’s Blueprint Medicines BPMC Stock Holding History

Total Clarity Wealth Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300
Closed -$24K – 146
2019
Q4 		$24K Buy
+300
New +$22.5K 0.02% 366

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Total Clarity Wealth Management's BPMC Position: Q1 2020 in Review

Total Clarity Wealth Management sold out of Blueprint Medicines (BPMC) in Q1 2020, closing a stake of 300 shares — an estimated $24K sold.

Total Clarity Wealth Management first reported a position in BPMC in Q4 2019 and held it in 1 quarter. The position peaked at $24K in Q4 2019. 213 funds tracked by Wall St. Rank hold BPMC as of Q1 2020.

  • Total Clarity Wealth Management reported no remaining Blueprint Medicines position as of Q1 2020 after selling out during the quarter.
  • Total Clarity Wealth Management sold 300 Blueprint Medicines shares in Q1 2020, an estimated $24K.
  • Total Clarity Wealth Management first reported a position in Blueprint Medicines in Q4 2019 and held it in 1 quarter.
  • Total Clarity Wealth Management's Blueprint Medicines position peaked at $24K in Q4 2019.
  • 213 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2020.

Based on Total Clarity Wealth Management's 13F filing for Q1 2020, filed 24 Apr 2020.